UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

How Cryo-EM Has Expanded Our Understanding of Membrane Transporters

Drug metabolism and disposition, 2023-08, Vol.51 (8), p.904-922

2023

Volltextzugriff (PDF)

Publisher Correction: The net electrostatic potential and hydration of ABCG2 affect substrate transport

Nature communications, 2024-10, Vol.15 (1), p.8956-1, Article 8956

2024

Volltextzugriff (PDF)

Impact of FDA-Approved Drugs on the Prostaglandin Transporter OATP2A1/SLCO2A1

Journal of pharmaceutical sciences, 2017-09, Vol.106 (9), p.2483-2490

2017

Volltextzugriff (PDF)

The net electrostatic potential and hydration of ABCG2 affect substrate transport

Nature communications, 2023-08, Vol.14 (1), p.5035-15, Article 5035

2023

Volltextzugriff (PDF)

Prostaglandin transporter (OATP2A1/SLCO2A1) contributes to local disposition of eicosapentaenoic acid-derived PGE3

Prostaglandins & other lipid mediators, 2016-01, Vol.122, p.10-17

2016

Volltextzugriff (PDF)

Functional Characterization of Apical Transporters Expressed in Rat Proximal Tubular Cells (PTCs) in Primary Culture

Molecular pharmaceutics, 2011-12, Vol.8 (6), p.2142-2150

2011

Volltextzugriff (PDF)

Using Pharmacology to Squeeze the Life Out of Childhood Leukemia, and Potential Strategies to Achieve Breakthroughs in Medulloblastoma Treatment

Pharmacological reviews, 2020-07, Vol.72 (3), p.668-691

2020

Volltextzugriff (PDF)

Assessing the ABCG2 Protein Interactome: a Potential Strategy to Disrupt ABCG2 Function

The FASEB journal, 2020-04, Vol.34 (S1), p.1-1

2020

Volltextzugriff (PDF)

Locked in place: Deciphering the conformational impairment caused by tumor-acquired somatic mutation Q393K in ABCG2

Biophysical journal, 2024-02, Vol.123 (3), p.119a-119a

2024

Volltextzugriff (PDF)

ABCG2 requires a single aromatic amino acid to “clamp” substrates and inhibitors into the binding pocket

The FASEB journal, 2020-04, Vol.34 (4), p.4890-4903

2020

Volltextzugriff (PDF)

An Evolutionarily Conserved Residue in ABCG2 Regulates the Transport Cycle and Inhibitor Activity

The FASEB journal, 2022-05, Vol.36 (S1), p.n/a

2022

Volltextzugriff (PDF)

Developing Inhibitors that Exploit ABCG2 and Cancer Dependencies to Improve Therapeutic Outcome

The FASEB journal, 2019-04, Vol.33 (S1), p.675.15-675.15

2019

Volltextzugriff (PDF)

Determining the Molecular Characteristics of How Ligands Interact with an ABC Transporter

The FASEB journal, 2019-04, Vol.33 (S1), p.507.4-507.4

2019

Volltextzugriff (PDF)

Tumor-acquired somatic mutation affects conformation to abolish ABCG2-mediated drug resistance

Drug resistance updates, 2024-03, Vol.73, p.101066, Article 101066

2024

Volltextzugriff (PDF)

A Single Amino Acid in ABCG2 is Essential for Clamping Substrates and Inhibitors into the Binding Pocket

The FASEB journal, 2020-04, Vol.34 (S1), p.1-1

2020

Volltextzugriff (PDF)

Is Inhibitor Binding the Sole Requirement in Determining Inhibition of ABCG2 Mediated Transport?

The FASEB journal, 2018-04, Vol.32 (S1), p.693.9-693.9

2018

Volltextzugriff (PDF)

Carrier-Mediated Prodrug Uptake to Improve the Oral Bioavailability of Polar Drugs: An Application to an Oseltamivir Analogue

Journal of pharmaceutical sciences, 2016-02, Vol.105 (2), p.925-934

2016

Volltextzugriff (PDF)

Carrier-Mediated Prodrug Uptake to Improve the Oral Bioavailability of Polar Drugs: An Application to an Oseltamivir Analogue: Pharmacokinetics, Pharmacodynamics and Drug Transport and Metabolism

Journal of pharmaceutical sciences, 2016-02, Vol.105 (2), p.925-934

2016

Volltextzugriff (PDF)

Exploiting ABCG2 Inhibition to Improve Cancer Therapy

Proceedings for Annual Meeting of The Japanese Pharmacological Society, 2018, Vol.WCP2018, p.OR34-4

2018

Volltextzugriff (PDF)

1 – 19 von 19

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(19)

Sprache

Englisch
(19)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

How Cryo-EM Has Expanded Our Understanding of Membrane Transporters

Publisher Correction: The net electrostatic potential and hydration of ABCG2 affect substrate transport

Impact of FDA-Approved Drugs on the Prostaglandin Transporter OATP2A1/SLCO2A1

The net electrostatic potential and hydration of ABCG2 affect substrate transport

Prostaglandin transporter (OATP2A1/SLCO2A1) contributes to local disposition of eicosapentaenoic acid-derived PGE3

Functional Characterization of Apical Transporters Expressed in Rat Proximal Tubular Cells (PTCs) in Primary Culture

Using Pharmacology to Squeeze the Life Out of Childhood Leukemia, and Potential Strategies to Achieve Breakthroughs in Medulloblastoma Treatment

Assessing the ABCG2 Protein Interactome: a Potential Strategy to Disrupt ABCG2 Function

Locked in place: Deciphering the conformational impairment caused by tumor-acquired somatic mutation Q393K in ABCG2

ABCG2 requires a single aromatic amino acid to “clamp” substrates and inhibitors into the binding pocket

An Evolutionarily Conserved Residue in ABCG2 Regulates the Transport Cycle and Inhibitor Activity

Developing Inhibitors that Exploit ABCG2 and Cancer Dependencies to Improve Therapeutic Outcome

Determining the Molecular Characteristics of How Ligands Interact with an ABC Transporter

Tumor-acquired somatic mutation affects conformation to abolish ABCG2-mediated drug resistance

A Single Amino Acid in ABCG2 is Essential for Clamping Substrates and Inhibitors into the Binding Pocket

Is Inhibitor Binding the Sole Requirement in Determining Inhibition of ABCG2 Mediated Transport?

Carrier-Mediated Prodrug Uptake to Improve the Oral Bioavailability of Polar Drugs: An Application to an Oseltamivir Analogue

Carrier-Mediated Prodrug Uptake to Improve the Oral Bioavailability of Polar Drugs: An Application to an Oseltamivir Analogue: Pharmacokinetics, Pharmacodynamics and Drug Transport and Metabolism

Exploiting ABCG2 Inhibition to Improve Cancer Therapy

Suchergebnisse filtern